EMX2OS
geneOn this page
Also known as NCRNA00045EMX2-AS1
Summary
EMX2OS (EMX2 opposite strand/antisense RNA, HGNC:18511) is a long non-coding RNA gene on chromosome 10q26.11.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18511 |
| Approved symbol | EMX2OS |
| Name | EMX2 opposite strand/antisense RNA |
| Location | 10q26.11 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | NCRNA00045, EMX2-AS1 |
| Ensembl gene | ENSG00000229847 |
| Ensembl biotype | lncRNA |
| OMIM | 607637 |
| Entrez | 196047 |
| RNAcentral | URS000073968D — lncRNA, 7282 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 12 lncRNA
ENST00000412075, ENST00000423419, ENST00000424371, ENST00000440007, ENST00000450314, ENST00000551288, ENST00000611404, ENST00000656309, ENST00000659715, ENST00000748259, ENST00000748260, ENST00000748261
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000412075 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001629082 | 117476357 | 117477173 |
| ENSE00001717287 | 117473215 | 117473422 |
Expression profiles
Bgee: expression breadth ubiquitous, 205 present calls, max score 96.95.
FANTOM5 (CAGE): breadth broad, TPM avg 6.7822 / max 249.6683, expressed in 565 samples.
FANTOM5 promoters (12 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 111614 | 1.3551 | 341 |
| 111611 | 1.1275 | 316 |
| 111612 | 1.0638 | 321 |
| 111616 | 0.8741 | 334 |
| 111615 | 0.6560 | 260 |
| 111608 | 0.4726 | 173 |
| 111618 | 0.3522 | 139 |
| 111617 | 0.3044 | 169 |
| 111610 | 0.2611 | 126 |
| 111609 | 0.1652 | 85 |
Top tissues by expression
243 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| corpus epididymis | UBERON:0004359 | 96.95 | gold quality |
| kidney epithelium | UBERON:0004819 | 96.87 | gold quality |
| caput epididymis | UBERON:0004358 | 96.52 | gold quality |
| cauda epididymis | UBERON:0004360 | 96.13 | gold quality |
| seminal vesicle | UBERON:0000998 | 96.03 | gold quality |
| oviduct epithelium | UBERON:0004804 | 94.87 | gold quality |
| body of uterus | UBERON:0009853 | 94.30 | gold quality |
| right uterine tube | UBERON:0001302 | 94.21 | gold quality |
| fallopian tube | UBERON:0003889 | 93.01 | gold quality |
| endocervix | UBERON:0000458 | 92.21 | gold quality |
| myometrium | UBERON:0001296 | 92.11 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 92.07 | gold quality |
| ventricular zone | UBERON:0003053 | 90.35 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 90.25 | gold quality |
| uterus | UBERON:0000995 | 89.73 | gold quality |
| left uterine tube | UBERON:0001303 | 89.68 | gold quality |
| kidney | UBERON:0002113 | 89.59 | gold quality |
| renal medulla | UBERON:0000362 | 89.06 | gold quality |
| metanephros cortex | UBERON:0010533 | 88.67 | gold quality |
| caudate nucleus | UBERON:0001873 | 88.64 | gold quality |
| entorhinal cortex | UBERON:0002728 | 88.32 | gold quality |
| decidua | UBERON:0002450 | 88.18 | gold quality |
| uterine cervix | UBERON:0000002 | 88.02 | gold quality |
| amygdala | UBERON:0001876 | 87.64 | gold quality |
| temporal lobe | UBERON:0001871 | 87.34 | gold quality |
| endometrium | UBERON:0001295 | 87.20 | gold quality |
| ectocervix | UBERON:0012249 | 86.12 | gold quality |
| endothelial cell | CL:0000115 | 86.08 | silver quality |
| ganglionic eminence | UBERON:0004023 | 86.04 | gold quality |
| primary visual cortex | UBERON:0002436 | 85.99 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 20.25 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 4)
- In the three variants of papillary thyroid cancer (PTC), EMX2 was significantly downregulated in classical PTC, while EMX2OS was significantly downregulated in follicular and classical PTC, compared with adjacent normal tissues. Kaplan-Meier survival curves showed that EMX2 and EMX2OS expression was not related to relapse-free survival in follicular PTC. (PMID:30576338)
- EMX2OS plays a prognosis-associated enhancer RNA role in gastric cancer. (PMID:34731149)
- EMX2OS Delays Wilms’Tumor Progression via Targeting miR-654-3p. (PMID:35181613)
- EMX2OS targeting IGF2BP1 represses Wilms’ tumour stemness,epithelial-mesenchymal transition and metastasis. (PMID:36722215)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): celiac disease, congenital hypogonadotropic hypogonadism, pit and fissure surface dental caries, schizencephaly